Boehringer Ingelheim Pharmaceuticals is recalling 128 bottles of Mobic (meloxicam) 15 mg tablets because they were packaged with the wrong information insert. Mobic is a prescription medication used to treat pain and inflammation from arthritis. Because the package insert contains critical safety information, usage instructions, and warning details for patients and healthcare providers, having the incorrect insert could lead to a misunderstanding of how to use the medication safely or a failure to recognize important side effects. This recall affects 100-count bottles from one specific lot distributed in Colorado and Ohio.
The incorrect package insert may provide inaccurate dosage instructions or omit vital safety warnings, potentially leading to improper use of the medication or unrecognized adverse reactions.
Patient and pharmacist guidance and product return.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.